Your browser doesn't support javascript.
loading
Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.
Espinel-Ingroff, A; Arendrup, M; Cantón, E; Cordoba, S; Dannaoui, E; García-Rodríguez, J; Gonzalez, G M; Govender, N P; Martin-Mazuelos, E; Lackner, M; Lass-Flörl, C; Linares Sicilia, M J; Rodriguez-Iglesias, M A; Pelaez, T; Shields, R K; Garcia-Effron, G; Guinea, J; Sanguinetti, M; Turnidge, J.
Affiliation
  • Espinel-Ingroff A; VCU Medical Center, Richmond, Virginia, USA avingrof@vcu.edu.
  • Arendrup M; Unit for Mycology, Statens Serum Institut, Copenhagen, Denmark, and Copenhagen University, Rigshospitalet, Copenhagen, Denmark.
  • Cantón E; Grupo Infección Grave, Instituto Investigación Sanitaria La Fe, Valencia, Spain.
  • Cordoba S; Instituto Nacional de Enfermedades Infecciosas Dr. C. G. Malbrán, Buenos Aires, Argentina.
  • Dannaoui E; Université Paris-Descartes, Faculté de Médecine, APHP, Hôpital Européen Georges Pompidou, Unité de Parasitologie-Mycologie, Service de Microbiologie, Paris, France.
  • García-Rodríguez J; Hospital Universitario La Paz, Madrid, Spain.
  • Gonzalez GM; Universidad Autonóma de Nuevo León, Monterrey, Nuevo León, México.
  • Govender NP; National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Martin-Mazuelos E; Unidad de Gestion Clinica de Enfermedades Infecciosas y Microbiologia, Hospital Universitario Valme, Seville, Spain.
  • Lackner M; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Lass-Flörl C; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Linares Sicilia MJ; Facultad de Medicina, Universidad de Córdoba, H. U. Reina Sofía, Córdoba, Spain.
  • Rodriguez-Iglesias MA; Hospital Universitario Puerta del Mar, Cádiz, Spain.
  • Pelaez T; Servicio de Microbiología, Hospital Universitario Central de Asturias, Asturias, Spain.
  • Shields RK; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Garcia-Effron G; Laboratorio de Micología y Diagnóstico Molecular-Facultad de Bioquímica y Ciencias Biológicas-Universidad Nacional del Litoral, Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), CCT, Santa Fe, Argentina.
  • Guinea J; Servicio de Microbiología Clínica y Enfermedades Infecciosas-VIH, Hospital General Universitario Gregorio Marañon, and Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
  • Sanguinetti M; Institute of Microbiology and Institute of Hygiene, Universita Cattolica del Sacro Cuore, Rome, Italy.
  • Turnidge J; University of Adelaide, Adelaide, Australia.
Article in En | MEDLINE | ID: mdl-27799206
ABSTRACT
Method-dependent Etest epidemiological cutoff values (ECVs) are not available for susceptibility testing of either Candida or Aspergillus species with amphotericin B or echinocandins. In addition, reference caspofungin MICs for Candida spp. are unreliable. Candida and Aspergillus species wild-type (WT) Etest MIC distributions (microorganisms in a species-drug combination with no detectable phenotypic resistance) were established for 4,341 Candida albicans, 113 C. dubliniensis, 1,683 C. glabrata species complex (SC), 709 C. krusei, 767 C. parapsilosis SC, 796 C. tropicalis, 1,637 Aspergillus fumigatus SC, 238 A. flavus SC, 321 A. niger SC, and 247 A. terreus SC isolates. Etest MICs from 15 laboratories (in Argentina, Europe, Mexico, South Africa, and the United States) were pooled to establish Etest ECVs. Anidulafungin, caspofungin, micafungin, and amphotericin B ECVs (in micrograms per milliliter) encompassing ≥97.5% of the statistically modeled population were 0.016, 0.5, 0.03, and 1 for C. albicans; 0.03, 1, 0.03, and 2 for C. glabrata SC; 0.06, 1, 0.25, and 4 for C. krusei; 8, 4, 2, and 2 for C. parapsilosis SC; and 0.03, 1, 0.12, and 2 for C. tropicalis The amphotericin B ECV was 0.25 µg/ml for C. dubliniensis and 2, 8, 2, and 16 µg/ml for the complexes of A. fumigatus, A. flavus, A. niger, and A. terreus, respectively. While anidulafungin Etest ECVs classified 92% of the Candida fks mutants evaluated as non-WT, the performance was lower for caspofungin (75%) and micafungin (84%) cutoffs. Finally, although anidulafungin (as an echinocandin surrogate susceptibility marker) and amphotericin B ECVs should identify Candida and Aspergillus isolates with reduced susceptibility to these agents using the Etest, these ECVs will not categorize a fungal isolate as susceptible or resistant, as breakpoints do.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aspergillus / Candida / Amphotericin B / Drug Resistance, Fungal / Echinocandins / Antifungal Agents Type of study: Clinical_trials / Diagnostic_studies Country/Region as subject: Africa / America do norte / Europa Language: En Journal: Antimicrob Agents Chemother Year: 2017 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aspergillus / Candida / Amphotericin B / Drug Resistance, Fungal / Echinocandins / Antifungal Agents Type of study: Clinical_trials / Diagnostic_studies Country/Region as subject: Africa / America do norte / Europa Language: En Journal: Antimicrob Agents Chemother Year: 2017 Document type: Article Affiliation country: Estados Unidos